| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c74e2bdccbf532309034a81441288ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0697ef21faf9c60849b9a1998911060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc9b33c7068637b8fc4ec07aae7b3ad2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_343c1e9dd38a1e6b4960fbe32fbe6238 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-165 |
| filingDate |
2004-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bae0df45c3b6e4e312eaf464b1f8b36a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a809b8d2371139ff360e4539d2d8c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6828563091c09c0465cda6cb56b47e1c |
| publicationDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005018538-A2 |
| titleOfInvention |
Severe acute respiratory syndrome (sars) polypeptides, antibodies to sars polypeptides and the use thereof in diagnostic, vaccination and therapeutic applications |
| abstract |
Severe Acute Respiratory Syndrome (SARS) polypeptides and bioconjugates of the polypeptides and a hyaluronic acid polymer are described. The bioconjugates of SARS antigenic polypeptides can be immobilized on a solid support and used to diagnose patients infected with the SARS virus. The immobilized bioconjugates can also be used to isolate SARS antibodies from the serum of recovered SARS patients. Pharmaceutical compositions comprising the bioconjugates are also disclosed. The pharmaceutical compositions can be used to treat patients infected with the SARS virus or to immunize patients believed to have been exposed to the SARS virus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008060331-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021198999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014134439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021229077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7728110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341526-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008060331-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103575-B2 |
| priorityDate |
2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |